AxoGen Competitors and Similar CompaniesClear all

AxoGen's competitors and similar companies include Shanghai Rightongene Biotechnology.
AxoGen
AxoGen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Shanghai Rightongene Biotechnology
Shanghai Rightongene Biotechnology
Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products.
Founding Date
Founding Date
2002
Founding Date
2012
Type
Type
Public
Type
Public
Tags
Locations
Locations
Alachua, US HQ
Burleson, US
Locations
CN HQ
Employees
Employees
37133% increase
Employees
401
Valuation ($)
Valuation ($)
611.9 m
Valuation ($)
132.9 m

Financial

Revenue (est.)
Revenue (est.)
$225.2m (FY, 2025)
Revenue (est.)
¥170.7m (FY, 2025)
Cost of goods
Cost of goods
$57.9m (FY, 2025)
Cost of goods
¥43.6m (FY, 2025)
Gross profit
Gross profit
$167.4m (FY, 2025)
Gross profit
¥130.3m (FY, 2025)
Net income
Net income
($15.7m) (FY, 2025)
Net income
(¥60.4m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Shanghai Rightongene Biotechnology
HQ
CN
Employees
401

Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products.

View company